LIGAND PHARMACEUTICALS INC's ticker is LGND and the CUSIP is 53220K504. A total of 243 filers reported holding LIGAND PHARMACEUTICALS INC in Q4 2020. The put-call ratio across all filers is 4.76 and the average weighting 0.3%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q4 2021 | $980,000 | +357.9% | 6,348 | +311.7% | 0.00% | +100.0% |
| Q3 2021 | $214,000 | +5.9% | 1,542 | 0.0% | 0.00% | 0.0% |
| Q2 2021 | $202,000 | -15.5% | 1,542 | -1.8% | 0.00% | 0.0% |
| Q1 2021 | $239,000 | +2.6% | 1,571 | -35.8% | 0.00% | 0.0% |
| Q3 2020 | $233,000 | -11.7% | 2,448 | +3.5% | 0.00% | 0.0% |
| Q2 2020 | $264,000 | +21.7% | 2,365 | +13.2% | 0.00% | 0.0% |
| Q4 2019 | $217,000 | -16.2% | 2,090 | -19.8% | 0.00% | 0.0% |
| Q3 2019 | $259,000 | -54.7% | 2,605 | -48.0% | 0.00% | -66.7% |
| Q2 2019 | $572,000 | +18.4% | 5,011 | +30.3% | 0.00% | +50.0% |
| Q1 2019 | $483,000 | +10.3% | 3,847 | +141.0% | 0.00% | 0.0% |
| Q3 2018 | $438,000 | +101.8% | 1,596 | +52.3% | 0.00% | +100.0% |
| Q2 2018 | $217,000 | +9.0% | 1,048 | -13.3% | 0.00% | 0.0% |
| Q1 2018 | $199,000 | -2.9% | 1,209 | -19.2% | 0.00% | 0.0% |
| Q4 2017 | $205,000 | – | 1,497 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Knott David M Jr | 115,000 | $8,459 | 3.32% |
| VILLERE ST DENIS J & CO LLC | 480,807 | $35,368,162 | 2.57% |
| Chicago Capital, LLC | 449,508 | $33,065,822 | 1.64% |
| RICE HALL JAMES & ASSOCIATES, LLC | 288,345 | $21,210,681 | 1.20% |
| Smith, Graham & Co., Investment Advisors, LP | 65,163 | $4,793,390 | 0.58% |
| Stephens Investment Management Group LLC | 455,089 | $33,476,347 | 0.56% |
| CARDINAL CAPITAL MANAGEMENT LLC /CT | 201,993 | $14,858,605 | 0.53% |
| WOODSTOCK CORP | 52,604 | $3,869,550 | 0.49% |
| Court Place Advisors, LLC | 15,533 | $1,142,607 | 0.41% |
| Jackson Creek Investment Advisors LLC | 12,726 | $936 | 0.39% |